Health Insurance - Prescriptions for Gender-Affirming Care and Hormone Therapy - Coverage and Dispensing Requirements

Summary

The bill mandates that insurers, nonprofit health plans, and HMOs in Maryland cover a single dispensing of qualifying gender‑affirming or hormone‑therapy drugs for up to 12 months. It also changes pharmacy rules so that, after Jan. 1 2027, such prescriptions may be dispensed in a 12‑month supply rather than the current 90‑day limit, with certain exceptions. The measure is intended to improve access to these medications.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share